Barclays’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.3K Sell
5,775
-393,076
-99% -$3.52M ﹤0.01% 4286
2025
Q4
$3.23M Buy
398,851
+354,771
+805% +$3.88M ﹤0.01% 2577
2025
Q3
$626K Sell
44,080
-14,355
-25% -$190K ﹤0.01% 3668
2025
Q2
$763K Buy
58,435
+3,178
+6% +$43.7K ﹤0.01% 3513
2025
Q1
$823K Sell
55,257
-16,816
-23% -$289K ﹤0.01% 3226
2024
Q4
$1.31M Sell
72,073
-8,204
-10% -$110K ﹤0.01% 3191
2024
Q3
$1.08M Buy
80,277
+43,372
+118% +$639K ﹤0.01% 3308
2024
Q2
$511K Sell
36,905
-5,658
-13% -$89.6K ﹤0.01% 3034
2024
Q1
$797K Sell
42,563
-35,826
-46% -$717K ﹤0.01% 3293
2023
Q4
$1.77M Buy
78,389
+35,126
+81% +$762K ﹤0.01% 3010
2023
Q3
$1.07M Buy
43,263
+11,718
+37% +$295K ﹤0.01% 2287
2023
Q2
$886K Buy
31,545
+5,332
+20% +$132K ﹤0.01% 2383
2023
Q1
$585K Buy
26,213
+1,756
+7% +$46K ﹤0.01% 3161
2022
Q4
$650K Buy
24,457
+12,039
+97% +$393K ﹤0.01% 3131
2022
Q3
$352K Sell
12,418
-10,917
-47% -$281K ﹤0.01% 2883
2022
Q2
$486K Sell
23,335
-15,044
-39% -$282K ﹤0.01% 2884
2022
Q1
$831K Sell
38,379
-8,477
-18% -$184K ﹤0.01% 2545
2021
Q4
$1.3M Buy
46,856
+14,363
+44% +$348K ﹤0.01% 2659
2021
Q3
$690K Buy
32,493
+14,067
+76% +$264K ﹤0.01% 3008
2021
Q2
$304K Sell
18,426
-25,858
-58% -$395K ﹤0.01% 3348
2021
Q1
$553K Buy
44,284
+5,291
+14% +$56.1K ﹤0.01% 3121
2020
Q4
$345K Sell
38,993
-3,808
-9% -$31K ﹤0.01% 3471
2020
Q3
$278K Buy
42,801
+9,640
+29% +$61.1K ﹤0.01% 3631
2020
Q2
$204K Buy
33,161
+3,086
+10% +$18.9K ﹤0.01% 4058
2020
Q1
$203K Sell
30,075
-24,466
-45% -$232K ﹤0.01% 4283
2019
Q4
$633K Buy
54,541
+17,886
+49% +$202K ﹤0.01% 4093
2019
Q3
$377K Sell
36,655
-5,019
-12% -$49.4K ﹤0.01% 4468
2019
Q2
$391K Buy
41,674
+11,321
+37% +$87.1K ﹤0.01% 4545
2019
Q1
$213K Buy
30,353
+15,140
+100% +$130K ﹤0.01% 4772
2018
Q4
$112K Sell
15,213
-23,858
-61% -$200K ﹤0.01% 4965
2018
Q3
$341K Buy
39,071
+20,240
+107% +$207K ﹤0.01% 4579
2018
Q2
$212K Buy
18,831
+6,548
+53% +$78.1K ﹤0.01% 4674
2018
Q1
$136K Buy
12,283
+6,665
+119% +$83.5K ﹤0.01% 5158
2017
Q4
$72K Buy
5,618
+4,473
+391% +$59.1K ﹤0.01% 5495
2017
Q3
$17K Sell
1,145
-2,738
-71% -$34.3K ﹤0.01% 5857
2017
Q2
$49K Sell
3,883
-7,325
-65% -$94.4K ﹤0.01% 5373
2017
Q1
$161K Buy
11,208
+662
+6% +$9.75K ﹤0.01% 4513
2016
Q4
$164K Buy
10,546
+9,897
+1,525% +$136K ﹤0.01% 4378
2016
Q3
$7K Buy
+649
New +$8.55K ﹤0.01% 5905
2016
Q2
Sell
-39,224
Closed -$431K 6339
2016
Q1
$431K Sell
39,224
-2,428
-6% -$30.9K ﹤0.01% 3275
2015
Q4
$666K Buy
41,652
+41,484
+24,693% +$660K ﹤0.01% 2960
2015
Q3
$2K Sell
168
-448
-73% -$6.08K ﹤0.01% 6306
2015
Q2
$7K Sell
616
-317
-34% -$3.59K ﹤0.01% 6257
2015
Q1
$11K Sell
933
-1,594
-63% -$18.3K ﹤0.01% 6167
2014
Q4
$30K Sell
2,527
-12,110
-83% -$124K ﹤0.01% 6056
2014
Q3
$131K Sell
14,637
-3,065
-17% -$23.5K ﹤0.01% 5108
2014
Q2
$106K Sell
17,702
-3,211
-15% -$21.2K ﹤0.01% 5365
2014
Q1
$167K Buy
20,913
+8,070
+63% +$79.4K ﹤0.01% 4959
2013
Q4
$116K Sell
12,843
-2,386
-16% -$16.5K ﹤0.01% 5509
2013
Q3
$92K Sell
15,229
-6,466
-30% -$37K ﹤0.01% 5673
2013
Q2
$112K Buy
+21,695
New +$111K ﹤0.01% 5698

Other funds holding CCRN